Shefferman Jesse 4

What Happened

• Jesse Shefferman, CEO, President and Director of Protara Therapeutics (TARA), had 8,732 shares withheld by the company on January 26, 2026 to satisfy tax obligations from the vesting of a Restricted Stock Unit (RSU) award. The withholding was at $6.67 per share, a total value of $58,242.
• This was a tax-withholding disposition (not an open-market sale or purchase) tied to RSU vesting rather than a trade intended to realize investment gains.

Key Details

• Transaction date and price: 2026-01-26 at $6.67 per share.
• Shares withheld/disposed: 8,732; total value reported $58,242.
• Transaction code/footnote: Code F (payment of exercise price or tax liability). Footnote F1: shares withheld to satisfy income tax obligations from an RSU award granted Jan 24, 2025.
• Shares owned after transaction: not specified in the provided filing.
• Filing date: Form 4 filed Jan 27, 2026 — appears timely based on the reported transaction date.

Context

• This was a cashless tax-withholding event common with RSU vesting: the company retained shares to cover income taxes rather than the insider selling shares on the open market.
• Such withholdings are routine administrative actions and do not necessarily indicate the insider's view on the company’s stock.